英文原著論文 "2006" Original Papers in English

緑色のタイトル部分をクリックすると、論文PDFが表示されます。

【 2006 年 】

  1. Abe K, Tawara S, Oi K, Hizume T, Uwatoku T, Fukumoto Y, Kaibuchi K, Shimokawa H. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice. J Cardiovasc Pharmacol. 48:280-285,2006.

  2. Chapados R, Abe K, Elliot J, Ihida-Stunbery K, McKean D, Gates AT, Kern M, Merklinger S, Plant A, Shimokawa H, Jones PL. ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling. Circ Res. 99:837-844,2006.

  3. Chida K, Otani H, Kohzuki M, Saito H, Kagaya Y, Takai Y, Takahashi S, Yamada S, Zuguchi M. The relationship between plasma BNP level and the myocardial phosphocreatine/adenosine triphosphate ratio determined by phosphorus-31 magnetic resonance spectroscopy in patients with dilated cardiomyopathy. Cardiology. 106:132-136,2006.

  4. Chida K, Saito H, Kagaya Y, Kohzuki M, Takai Y, Takahashi S, Yamada S, Zuguchi M. Indicators of the maximum radiation dose to the skin during percutaneous coronary intervention in different target vessels. Catheter Cardiovasc Interv. 68:236-241,2006.

  5. Endo H, Miura M, Hirose M, Takahashi J, Nakano M, Wakayama Y, Sugai Y, Kagaya Y, Watanabe J, Shirato K, Shimokawa H. Reduced inotropic effect of nifekalant in failing hearts in rats. J Pharmacol Exp Ther. 318:1102-1107,2006.

  6. Fukumoto Y, Ito A, Takeshita A, Sunagawa K, Shimokawa H. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coronary Art Dis. 17:63-70,2006.

  7. Furuyama T, Komori K, Shimokawa H, Matsumoto Y, Uwatoku T, Hirano K, Maehara Y. Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits. J Vasc Surg. 43:1249-1256,2006.

  8. Hizume T, Morikawa K, Takaki A, Abe K, Sunagawa K, Amano M, Kaibuchi K, Kubo C, Shimokawa H. Sustained elevation of serum cortisol level causes sensitization of coronary vasoconstricting responses in pigs in vivo - A possible link between stress and coronary vasospasm -. Circ Res. 99:767-775,2006.

  9. Kumagai K, Takahashi A, Yamauchi Y, Aonuma K. Ventricular tachycardia originating from the epicardium identified by intracoronary mapping using a PTCA guidewire. J Cardiovasc Electrophysiol. 17:670-673,2006.

  10. Kumagai K, Suzuki F, Aonuma K, Shimokawa H. Atrial tachycardia originating from the upper left atrial septum: demonstration of transseptal interatrial conduction using the infolded atrial walls. J Cardiovasc Electrophysiol. 17:907-911,2006.

  11. Kunii S, Sugawara J, Kimura Y, Imai N, Chisaka H, Hasegawa H, Koiwa Y, Kanai H, Okamura K. Fetal myocardial thickening measured by ultrasonic-based technique called 'phased-tracking method'. Fetal Diagn Ther. 21:458-465,2006.

  12. Miura M, Hata Y, Hiratyama K, Kita T, Noda Y, Fujisawa K, Shimokawa H, Ishibashi T. Critical role of the Rho-kinase pathway in TGF-β2-dependent collagen gel contraction by retinal pigment epithelial cells. Exp Eye Res. 82:849-859,2006.

  13. Ohashi J, Yasuda S, Miyazaki S, Shimizu S, Morii I, Kurita T, Kawamura A, Kamakura S, Nonogi N. Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride. J Cardiovasc Pharmacol. 48:274-279,2006.

  14. Peridsky Y, Heilman D, Haorah J, Zelivyanskaya M, Persidsky R, Weber GA, Shimokawa H, Kaibuchi K, Ikezu T. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood. 107:4770-4780,2006.

  15. Sadamatsu K, Shimokawa H, Tashiro H, Seto T, Yamamoto K. Different effects of simvastatin and losartan on cytokine levels in coronary artery disease. Am J Cardiovasc Drugs. 6:169-175,2006.

  16. Satoh K, Kagaya Y, Nakano M, Ito Y, Ohta J, Tada H, Karibe A, Minegishi N, Suzuki N, Yamamoto M, Ono M, Watanabe J, Shirao K, Ishii N, Sugamura K, Shimokawa H. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation. 113:1442-1450,2006.

  17. Sun X, Minohara M, Kikuchi H, Ishizu T, Tanaka M, Piao H, Osoegawa M, Ohyagi Y, Shimokawa H, Kira J. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis. J Neuroimmunol. 180:126-134,2006.

  18. Tada H, Kagaya K, Takeda M, Ohta J, Asaumi Y, Satoh K, Ito K, Karibe A, Shirato K, Minegishi N, Shimokawa H. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion. Cardiovasc Res. 71:466-477,2006.

  19. Takahashi K, Komaru T, Takeda S, Takeda M, Koshida R, Nakayama M, Kokusyo Y, Kawakami Y, Yamaguchi N, Miyazawa T, Shimokawa H, Shirato Y. gamma-tocopherol, but not alpha-tocopherol, potently inhibits neointimal formation induced by vascular injury in insulin resistant rats. J Mol Cell Cardiol. 41:544-554,2006.

  20. Tatsumi R, Yamada M, Katsuki Y, Okamoto S, Ishizaki J, Mizunoya W, Ikeuchi Y, Hattori A, Shimokawa H, Allen RE. Low-pH preparation of skeletal muscle satellite cells can be used to study activation in vitro. Int'l J Biochem Cell Biol. 38:1678-1685,2006.

  21. ter Keurs HE, Wakayama Y, Sugai Y, Price G, Y Kagaya, Boyden PA, Miura M, Stuyvers BD. Role of sarcomere mechanics and Ca2+ overload in Ca2+ waves and arrhythmias in rat cardiac muscle. Ann NY Acad Sci. 1080:248-267,2006.

  22. ter Keurs HE, Wakayama Y, Miura M, Shinozaki T, Stuyvers BD, Boyden PA, Landesberg A. Arrhythmogenic Ca2+ release from cardiac myofilaments. Prog Biophys Mol Biol. 90:1-3,151-171,2006.

  23. Watanabe J, Shinozaki T, Shiba N, Fukahori K, Koseki Y, Karibe A, Sakuma M, Miura M, Kagaya Y, Shirato K. Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure. Eur J Heart Fail. 8:237-242,2006.

  24. Yada T, Shimokawa H, Hiramatsu O, Shinozaki Y, Mori H, Kiyooka T, Goto M, Ogasawara Y, Kajiya F. Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo. Am J Physiol. 291:1138-1146,2006.

  25. Yada T, Shimokawa H, Kajiya F. Cardioprotective effect of hydroxyfasudil as a specific Rho-kinase inhibitor, on ischemia-reperfusion injury in canine coronary microvessels in vivo. Clin Hemorheol Microcirc. 34:177-183,2006.

  26. Yamada M, Tatsumi R, Kikuiri T, Okamoto S, Nonoshita S, Mizunoya W, Ikeuchi Y, Shimokawa H, Sunagawa K, Allen RE. Matrix metalloproteinases are involved in mechanical stretch-induced activation of skeletal muscle satellite cells. Muscle and Nerve. 34:313-319,2006.

  27. Yamagish T, Kato M, Koiwa Y, Hasegawa H, Kanai H. Usefulness of the measurement of carotid arterial wall elasticitys distribution in detection of early-stage atherosclerotic lesion by cigarette smoking. J Med Ultrasonics. 33:203-210,2006.

  28. Yasuda S, Miyazaki S, Kanda M, Goto Y, Suzuki M, Harano Y, Nonogi H. Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase. Eur Heart J. 27:1159-1165,2006.